• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » 7 medtech stories we missed this week: Oct. 20, 2017

7 medtech stories we missed this week: Oct. 20, 2017

October 20, 2017 By Danielle Kirsh

missed medtech
[Image from unsplash.com]
From InspireMD’s distribution deal to RenalGuard touting a new study, here are seven medtech stories we missed this week but thought were still worth a mention.

1. InspireMD inks Chile distribution deal

InspireMD announced in an Oct. 12 press release that it has signed a distribution deal with CorpMedical Chile to distribute the MGuard Prime Embolic Protection System (EPS). The MGuard Prime EPS treats acute coronary syndromes like acute myocardial infarctions.

2. Medacta launches MiniMed hip stem

Medacta has launched its MiniMAX Hip System in the U.S., according to an Oct. 12 press release. MiniMAX is an anatomical cementless stem that is engineered to provide enhanced fit and fill in the metaphyseal femur. It follows the natural shape of the femoral canal for minimally-invasive anterior and posterior hip replacement procedures.

3. Esaote launches MyLab 9 ultrasound

Esaote announced in an Oct. 13 press release that it has launched its MyLab 9 ultrasound platform. MyLab 9 has smart upgradability, remote serviceability, long-term maintenance options and transducer compatibility.

4. Subchondral system wins FDA nod for orthopedic screw system

Subchondral Solutions has received FDA 510(k) clearance for its S4 Screw System, according to a Sept. 29 press release. The S4 Screw System is a fenestrated cannulated screw set that is designed for osteochondral fractures of the joint. The clearance allows for the company to begin commercializing its products in the U.S.

5. Hill-Rom’s Welch Allyn, Honeywell ink remote patient monitoring deal

Welch Allyn announced in an Oct. 10 press release that its home medical devices are being offered with Honeywell’s remote patient monitoring platform. Welch Allyn Home 1700 Series Blood Pressure Monitor with SureBP technology and Welch Allyn Home Weight Scale are set to be offered as standard peripherals with Honeywell’s Genesis Touch remote patient monitoring kits. Genesis Touch uses Android tablets to a consumer-based, connected interface. Welch Allyn devices will pair wirelessly with Honeywell’s remote patient monitoring platform.

6. VivaSure launches PerQSeal study

VivaSure has enrolled its first patient in its Frontier IV clinical study, according to an Oct. 13 press release. The study is designed to expand the indications of its PerQseal large arteriotomy closure technology. PerQseal is the world’s first fully absorbable, patch-based large-bore percutaneous closure technology.

7. RenalGuard touts study

RenalGuard announced in an Oct. 12 press release the results of its study testing the feasibility and safety of RenalGuard use in reducing the risk of cardiac surgery-associated acute kidney injury (AKI). Patients who were having cardiopulmonary bypass surgery had an increased risk of developing AKI. RenalGuard Therapy was administered to the patients prior to surgery and was continued for six to 12 hours after the patient was transferred to the cardiac intensive care unit. None of the patients developed AKI in the 36 hours after surgery. One patient did develop cardiac tamponade eight hours after surgery and one patient developed paralytic ileus. Another patient was electively hemofiltered on day 3 after having acute right ventricular failure while one patient had a stroke one week after surgery. The study suggests that these events were not related to the RenalGuard system.

Here’s what we missed last week.

Filed Under: 510(k), Cardiovascular, Clinical Trials, Diagnostics, Food & Drug Administration (FDA), Implants, Orthopedics, Patient Monitoring, Regulatory/Compliance, Surgical, Ultrasound Tagged With: Esaote, Hillrom, Honeywell, InspireMD, Medacta, MedTech, RenalGuard Solutions, Subchondral Solutions, Vivasure, Welch Allyn

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy